Endorphin deficiency syndrome (EDS) is a condition where low levels of natural opioids in the brain contribute to addictive behaviors. Endorphins play a vital role in regulating pain, stress, and mood. When deficient, individuals may turn to substances like alcohol or opioids to compensate, leading to dependency. This biological predisposition highlights the neurochemical foundation of addiction. Treatments often involve therapies that stimulate endorphin production, such as exercise, acupuncture, and certain antidepressants. Recognizing EDS in addiction patients is crucial for developing tailored interventions that address this underlying imbalance, improving treatment outcomes and reducing the likelihood of relapse.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : The Storm Within: Neuropsychological Insights into Dysregulation and Substance Use in the Adolescent Brain.
Ann Marie Leonard Zabel, Curry College, United States
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, CIAPS, Cambridge, United Kingdom
Title : Creative exploration of the complexity of the pre-lapse experience in the addict to add retrospective insight
Eric A Kreuter, Cornerstone of Rhinebeck, United States
Title : Resilience in counseling: Processing grief for the addictions counselor
Jorja Jamison, Hazelden Betty Ford Graduate School, United States
Title : Resilience in counseling: Processing grief for the addictions counselor
Kayla Albers, Hazelden Betty Ford Graduate School, United States